12-53328276-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001173467.3(SP7):āc.1166A>Gā(p.Lys389Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000054 in 1,611,254 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001173467.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SP7 | NM_001173467.3 | c.1166A>G | p.Lys389Arg | missense_variant | 3/3 | ENST00000536324.4 | |
SP7 | NM_152860.2 | c.1166A>G | p.Lys389Arg | missense_variant | 2/2 | ||
SP7 | NM_001300837.2 | c.1112A>G | p.Lys371Arg | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SP7 | ENST00000536324.4 | c.1166A>G | p.Lys389Arg | missense_variant | 3/3 | 2 | NM_001173467.3 | P1 | |
SP7 | ENST00000303846.3 | c.1166A>G | p.Lys389Arg | missense_variant | 2/2 | 1 | P1 | ||
SP7 | ENST00000537210.2 | c.1112A>G | p.Lys371Arg | missense_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000614 AC: 15AN: 244192Hom.: 0 AF XY: 0.0000679 AC XY: 9AN XY: 132610
GnomAD4 exome AF: 0.0000528 AC: 77AN: 1459058Hom.: 0 Cov.: 29 AF XY: 0.0000496 AC XY: 36AN XY: 725672
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74404
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 389 of the SP7 protein (p.Lys389Arg). This variant is present in population databases (rs772101518, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SP7-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at